BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20200927T192759Z
CREATED:20200927T192759Z
LAST-MODIFIED:20200927T192759Z
UID:47216-1601546400-1601550000@globalbiodefense.com
SUMMARY:Accelerating Detection of Disease: UKRI Industry Briefing for Life Sciences Sector
DESCRIPTION:The UK Research and Innovation (UKRI)-funded Accelerating Detection of Disease (ADD) program will host a webinar on 1 October 2020 for life science companies to learn more about partnering and investment opportunities. \nOver the next four years the ADD program will recruit five million volunteers to support research intended to improve early detection\, risk stratification\, and early intervention for chronic diseases. \nADD volunteers will provide biological samples and health related data. With their consent\, volunteers’ data will be linked to NHS records\, and ADD will also offer volunteers feedback about their health\, if they choose. Some will be invited to provide repeat samples and join follow-on studies designed to test the potential of new diagnostic tests or treatments\, particularly if they’re at higher risk for certain diseases. \nThe unrivalled depth and detail of the ADD initiative will make it a unique resource for health research. Researchers from across academia and industry will have the chance to work with ADD to conduct studies that could improve the way we detect\, diagnose and treat diseases. \nSpeakers at the seminar include: \n\nAlison Cave\, Accelerating Detection of Disease challenge director at UK Research and Innovation\nAndrew Roddam\, CEO\, Early Disease Detection Research Project UK Ltd\, the charity that runs the ADD programme\nFiona Reddington\, Exec Director of Partnerships\, Early Disease Detection Research Project UK Ltd.\n\nADD is funded by £79 million from UKRI’s Industrial Strategy Challenge Fund which is expected to be matched by funding of up to £160 million from industry.
URL:https://globalbiodefense.com/event/accelerating-detection-of-disease-ukri-industry-briefing-for-life-sciences-sector/
CATEGORIES:Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200609
DTEND;VALUE=DATE:20200611
DTSTAMP:20200609T170801Z
CREATED:20200527T162939Z
LAST-MODIFIED:20200609T170801Z
UID:46303-1591660800-1591833599@globalbiodefense.com
SUMMARY:APG Advance Planning Briefing to Industry 2020
DESCRIPTION:The Aberdeen Proving Ground (APG) Advance Planning Briefing to Industry (APBI) and Technological Expo\, will be held virtually on 9-10 June 2020\, in lieu of being hosted live at APG\, MD. \nThe goal of the APG APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2021–2022. The Government will not hear formal bids from industry\, as the purpose of the APBI is for the Government to brief upcoming opportunities to industry to help it better understand Army capability requirements and shape its internal development efforts. \nDAY ONE \n0730–0830 Microsoft Teams Setup\n0830–0845 Welcome Remarks by MG Kilgo\n0850–0950 Army Contracting Command-Aberdeen Proving Ground\n0955–1125 Army Contracting Command-Aberdeen Proving Ground: Role of Division Chiefs\n1130–1245 Communications-Electronics Command Defense Logistics Agency-Aberdeen Proving Ground\n1330–1445 Program Executive Office Command Control Communications-Tactical & Network Cross-Functional Team\n1450–1520 Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense  Click to download slides for JPEO-CBRND presentation \nDAY TWO \n0730–0830 Microsoft Teams Setup\n0830–0930 Program Executive Office for Intelligence\, Electronic Warfare & Sensors\n0935–1005 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: C5 OTA Consortium Overview\n1010–1040 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: Multi-Domain Sensing System Contract Strategy Overview\n1045–1115 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: PM\, Electronic Warfare & Cyber 21 Strategic Planning Guidance\n1120–1150 Combat Capabilities Development Command\n1155–1225 Combat Capabilities Development Command-CMOSS\n1230–1300 Army Test and Evaulation Command\n1305–1335 A Message from the Office of Small Business Programs\n1340–1410 APG Garrison\n1415–1445 Closing Remarks by MG Kilgo \nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. There is no registration required for this event. \nIf you or your company has already purchased a ticket for APBI or reserved a table for the 2020 Team APG Tech Expo\, please contact MissionTix directly for a refund. MissionTix contact information is: 888-996-4774 or help@missiontix.com.
URL:https://globalbiodefense.com/event/apg-advance-planning-briefing-to-industry-2020/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/apg-abpi-cbrne-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200421T130000
DTEND;TZID=Europe/London:20200421T140000
DTSTAMP:20240623T192624Z
CREATED:20200406T161624Z
LAST-MODIFIED:20240623T192624Z
UID:42642-1587474000-1587477600@globalbiodefense.com
SUMMARY:DASA Biosensing Across Wide Areas Phase 2 Launch
DESCRIPTION:Join the Defence and Security Accelerator for a dial-in on 21 April 2020\, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. \nOne to Ones\nThere will be two opportunities for One to One dial-in sessions with the competition team: \n\nWednesday 21 April 2020 –  2.30pm to 4pm: Three slots available\nThursday 22 April 2020 – 1pm to 3pm: Four slots available\n\nThese pre-bookable 20 minute one to one slots will be with the competition team to discuss questions specific to your proposal. Slots are on a first come\, first serve basis. \nPlease note: \n\na separate link will be sent to you on your ticket confirmation to register for a one to one slot\ndetails of the dial in will be sent before the meeting commences\nif the event is oversubscribed\, we may place a limitation on the number of attendees from a single organisation\n\n// \nREAD MORE: UK Launches Wide-Area Biosensor Competition
URL:https://globalbiodefense.com/event/dasa-biosensing-across-wide-areas-phase-2-launch/
CATEGORIES:Conference,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/04/97aef6bbedcf01db65e877ee6755e43d.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200316
DTEND;VALUE=DATE:20200318
DTSTAMP:20200223T181226Z
CREATED:20200223T173102Z
LAST-MODIFIED:20200223T181226Z
UID:40151-1584316800-1584489599@globalbiodefense.com
SUMMARY:IABS-CEPI Vaccine Technology Platforms Meeting
DESCRIPTION:A cross-learning symposium on vaccine licensure based on technology platforms\, the IABS-CEPI-ZAPI Technology Platforms Meeting\, will take place 16-17 March 2020 in Brussels\, Belgium. \nThe scientific committee for this workshop is co-Chaired by: \n\nDaniel Brasseur\, former CHMP-PDCO-VWP chair at EMA; CEPI consultant\nMurray Lumpkin\, former Deputy Director\, FDA; Bill & Melinda Gates Foundation\n\nHighlighted topics of interest on the agenda include: \n\nWHO regulatory preparedness activities to facilitate access to emergency vaccines\nHuman influenza vaccine successes and failures\nLessons for emergency preparedness leaned from Ebola vaccine development and licensure\nRegulatory approach to vaccine tech platforms: FDA perspective\, EU approach\, AVAREF\, Asian regulators\nAdvanced human vaccines in the pipeline (viral vectors\, VSV-Measles-ChAd…) and RNA\, DNA technologies\nTo what extent can clinical trials be pre-arranged?\nDetermining what is platform generic vs. platform specific in manufacturing and quality control\nChallenges to prove vaccine efficacy for outbreak vaccines and mitigating risk\nStreamlining regulatory acceptance from ‘tried and true’ vaccine platforms\n\nIn addition\, CEPI will review its current portfolio and examples of vaccine candidates based on technology platforms. \nMembers of the Scientific Committee include: \n\nDr. Barney Graham\, NIH\, Deputy Director and Chief\, Viral Pathogenesis Laboratory\nDr. Mélanie Saville\, Director\, Vaccine Development\, CEPI\nProf. Dr. Johan Neyts\, Rega Institute Louvain\, Belgium\, specialist of DNA vaccine PLLAV\nDr. Marion Gruber\, FDA\, Director\, Office of Vaccine Research and Review – CBER\nDr. Ivo Classen\, EMA\, Head of Veterinary Medicines Division\nDr. Marco Cavaleri\, EMA\, Head of Anti-infectives and Vaccines\nProf Dr. Jeffery Almond\, Oxford University; Chairman of the Board\, Osivax\nDr. Jean-Christophe Audonnet\, Senior Director\, Vaccines R&D; ZAPI Project Coordinator;\nBoehringer Ingelheim Animal Health\nDr. Emmanuel Hanon\, Senior Vice President\, Head of R&D\, GSK Vaccines\nDr Ajoy Chakrabarti\, Bill & Melinda Gates Foundation Vaccine Development\nDr Steve Black\, The Brighton Collaboration\, Task Force for Global Health\n\nRegister now for the IABS-CEPI Technology Platforms Meeting
URL:https://globalbiodefense.com/event/iabs-cepi-vaccine-technology-platforms-meeting/
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191211
DTEND;VALUE=DATE:20191212
DTSTAMP:20191117T030306Z
CREATED:20191117T023811Z
LAST-MODIFIED:20191117T030306Z
UID:34095-1576022400-1576108799@globalbiodefense.com
SUMMARY:DARPA DIGET Proposers Day - Detect It with Gene Editing Technologies
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Proposers Day for the potential proposer community in support of a planned Broad Agency Announcement (BAA) for the DIGET (Detect It with Gene Editing Technologies) Program. \nThe Proposers Day will be held on December 11\, 2019 from 8:00 AM to 6:00 PM ET at the Hyatt Regency in Atlanta\, GA. \nThe DoD requires timely and comprehensive threat detection to support overall readiness\, counter the spread of disease\, and promote stabilization missions. The DIGET program aims to deliver this capability\, leveraging advances in gene editing technologies to develop low-cost\, high-trust\, rapidly reconfigurable\, and fieldable diagnostic (Dx) and biosurveillance (BSV) technologies to enable detection of any threat\, anytime\, anywhere. \nThe Proposers Day goals include:\n1. Introduce the DIGET program vision and goals;\n2. Explain the mechanics of a DARPA program in general and the objectives and milestones\nof this program in particular; and\n3. Encourage and promote teaming arrangements among organizations that have the relevant\nexpertise\, research facilities\, and capabilities for executing research and development\nresponsive to the DIGET program goals. \nThe Proposers Day will include brief overview presentations by government personnel as well as\nan information session to respond to questions from participants. Potential performers can\nhighlight their technical capabilities through “lightning” talks such that teaming relationships can\nbe developed. Lightning talk presentations will be made accessible to the proposer community on\nthe DIGET program website after presentation at the Proposers Day. It is expected that DIGET\nwill require strong teaming efforts to successfully innovate and integrate critical technologies\nnecessary to meet the metrics of the program. Private sidebar meetings with the DARPA\ngovernment team and potential proposer teams can be scheduled beforehand on the registration\nwebsite. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding.\nInformation relayed during the Proposers Day will be made available on the BTO section of the\nDARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nInterested attendees are invited to present a brief one-slide PowerPoint summary of their interests\, capabilities\, and teaming goals. Speakers will be allowed 3 minutes for discussion during a\n“lightning” presentation session at Proposers Day. Presentations consisting of multiple slides will\nnot be granted a time slot. Requests for lightning talks and sidebar meetings will be accepted on\na first-come basis. All presentations must be emailed to DARPA-SN-20-12@darpa.mil\nno later than 12:00 PM ET on December 2\, 2019. Specific content\, communications\, networking\,\nand team formation are the sole responsibility of the participants. \nRegistration Information:\nPLEASE NOTE: Registration closes on December 2\, 2019 at 12:00 PM ET. \nRegistration is limited by the venue capacity\, and early registration is strongly recommended. The\nregistration cutoff date is December 2\, 2019 at 12:00 PM EST\, or once attendance capacity is met\,\nwhichever comes first. There will be no on-site registration. \nParticipants must register in advance through the registration website. There will be a $25\nregistration fee for the Proposers Day. Early registration is strongly recommended. Due to space\nlimitations\, attendance for the Proposers Day will be limited to the first 150 registrants. Interested\nparties are encouraged to coordinate attendance internally within their organizations prior to\nregistration. Attendance is limited to no more than two representatives per division/department.\nIndividuals that are unable to register because the deadline has occurred or capacity has been\nreached will be added to a waitlist. If slots remain open after registration closes or become\navailable due to cancellations\, the slots will be filled on a first-come\, first-serve basis from the\nwaitlist. An online registration form and various other meeting details can be found at the\nregistration website: https://events.sa-meetings.com/DIGETProposersDay. \nPotential proposing teams are not required to attend Proposers Day\, although participation is\nstrongly encouraged. \n\n\n\n\nContact Information\nPlease direct all questions to DARPA-SN-20-12@darpa.mil and refer to the DIGET Proposers Day (DARPA-SN-20-12) in all correspondence. \nGlobal Biodefense is a news publication and not directly responsible for this event. Information is subject to change. Please contact the event organizers for the most up-to-date information.
URL:https://globalbiodefense.com/event/darpa-diget-proposers-day/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191205
DTSTAMP:20191204T193020Z
CREATED:20191102T054424Z
LAST-MODIFIED:20191204T193020Z
UID:34810-1575417600-1575503999@globalbiodefense.com
SUMMARY:Personalized Protective Biosystem (PPB) Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting and webinar covering the new Personalized Protective Biosystem (PPB) program on Dec 4\, 2019 in Arlington\, Va. \nPPB aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against chemical and biological threats. The program comprises two technical areas: 1) reactive materials that prevent threat agent access to the body; 2) a configurable barrier countermeasure that neutralizes threat agents at vulnerable points of entry (i.e.\, skin\, airway\, ocular). \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xp8dU. The registration deadline is November 26\, 2019\, at 12:00 PM EST or when capacity is reached. Registrations for webinar attendance only are accepted through December 2\, 2019\, or until webinar capacity is reached. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the PPB Proposers Day is open only to registered potential applicants\, and not to the media or general public. \nDARPA anticipates sharing additional program details in a forthcoming Broad Agency Announcement to be posted to the https://beta.sam.gov/ website.
URL:https://globalbiodefense.com/event/personalized-protective-biosystem-ppb-proposers-day/
LOCATION:George Mason University Arlington Campus\, 3351 Fairfax Dr\, Arlington\, VA\, 22201\, United States
CATEGORIES:Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/cbrne-darpa-ppb-personalized-protective-biosystem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191112
DTEND;VALUE=DATE:20191114
DTSTAMP:20190928T155134Z
CREATED:20190928T155026Z
LAST-MODIFIED:20190928T155134Z
UID:30716-1573516800-1573689599@globalbiodefense.com
SUMMARY:General Membership Meeting of the Medical CBRN Defense Consortium and CWMD Consortium
DESCRIPTION:The Medical CBRN Defense Consortium and the Countering Weapons of Mass Destruction Consortium\, in conjunction with the JPEO-CBRND and DHS CWMD Office\, will host a consortia meeting and industry outreach event on 12-13 Nov 2019 in Bethesda\, Md. \nThis event will include multiple opportunities for Government\, industry\, and academia to interact and exchange information regarding upcoming business opportunities. \nThis event will focus on medical and non-medical CBRNE related requirements of the CBRN enterprise including the JPEO-CBRND\, DHS CWMD Office\, DTRA\, and others. \nAssistant Secretary McDonnell and other speakers will update participants on CWMD’s progress towards meeting its mission and expand on the Office’s current areas of emphasis. The event will include plenary sessions\, user panel\, and an expanded exhibit area. This event will include sessions with government\, industry\, academia\, and operational users who have an interest in countering chemical\, biological\, radiological\, and nuclear threats in the new CWMD mission space. \nMembership in MCDC is limited to US companies or US-based affiliates of foreign companies. Foreign companies cannot gain membership due to MCDC’s requirement that members obtain a DD2345 (military critical technical data agreement). However\, foreign companies can be subcontractors (team members) on projects awarded through the Other Transaction Agreement (OTA) as long as they can meet the terms and conditions of the OTA. The MCDC member awarded the project is responsible for flowing the applicable requirements down to the foreign company. \nThe Countering Weapons of Mass Destruction (CWMD) Consortium was formed in response to the Government’s expressed interest to establish an Other Transaction Agreement (OTA) with an eligible entity or group of entities\, to include industry\, academic\, and not-for-profit partners\, for advanced development efforts to support agencies that have a need to prototype new technologies related to Countering Weapons of Mass Destruction. The OTA Consortium is an enterprise partnership between the US Government (JPEO-CBRND) and the CWMD Consortium connected through a “contract-like” OTA.  This OTA operates outside the Federal Acquisition Regulations. \nFor more information and registration\, please contact the Medical CBRN Defense Consortium at MCDC@ati.org  or the CWMD Consortium cwmd@ati.org.
URL:https://globalbiodefense.com/event/general-membership-meeting-of-the-medical-cbrn-defense-consortium-and-cwmd-consortium/
LOCATION:Bethesda North Marriott Hotel & Convention Center\, 5701 Marinelli Rd\, Bethesda\, MD\, 20852\, United States
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191108
DTEND;VALUE=DATE:20191109
DTSTAMP:20240623T192726Z
CREATED:20191101T040408Z
LAST-MODIFIED:20240623T192726Z
UID:34125-1573171200-1573257599@globalbiodefense.com
SUMMARY:DHS CWMD Systems Support Directorate A&AS Pre-Solicitation Conference
DESCRIPTION:The Department of Homeland Security (DHS)\, Office of Procurement Operations (OPO)\, Countering Weapons of Mass Destruction (CWMD) intends to hold a Pre-Solicitation Conference for interested industry partners for the Systems Support Directorate (SSD)\, Operations Support Directorate (OSD)\, and Policy\, Plans\, and Analysis (PPA) Advisory and Assistance Services (A&AS) requirements on Friday\, November 8\, 2019. \nThe purpose of the Pre-Solicitation Conference is to discuss the SSD\, OSD\, and PPA requirements and address additional industry questions. \nWe have received many comments and questions regarding the limitation of future contracting and organizational conflict of interest clauses. In advance of posting our responses to industry comments and questions\, we can advise you that our intent is to revise those clauses in order to allow a vendor to compete as a prime and/or sub on all three A&AS awards (SSD\, OSD & PPA). \nThe government intends to post responses to industry comments received in response to the SSD\, OSD\, and PPA draft solicitations no later than 5:00 PM eastern time on Wednesday\, November 6\, 2019.
URL:https://globalbiodefense.com/event/dhs-cwmd-systems-support-directorate-aas-pre-solicitation-conference/
CATEGORIES:Conference,Industry Day
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191028
DTEND;VALUE=DATE:20191029
DTSTAMP:20191020T223743Z
CREATED:20191020T223743Z
LAST-MODIFIED:20191020T223743Z
UID:31050-1572220800-1572307199@globalbiodefense.com
SUMMARY:DARPA Proposers Day: Nucleic Acids On-Demand Worldwide (NOW)
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) will host a Proposers’ Day on October 28\, 2019 in Arlington\, Virginia. \nThe event will gather the planned proposer community in support of the Nucleic Acids On-Demand Worldwide (NOW) program\, which aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce\, formulate\, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA). \nThe Proposers Day will include brief overview presentations by government personnel\, an\ninformation session to respond to questions from participants\, “lightning” talks (three minutes\,\none PowerPoint slide)\, posters for potential proposers to highlight technical capabilities or to\npromote teaming\, and private sidebar meetings between the DARPA government team and\npotential proposer teams. \nParticipant presentations and sidebar meetings must be scheduled via the registration website. Lightning talk presentations will be made accessible to the proposer community on the NOW program website after presentation at the Proposers day. It is expected that NOW will require strong teaming efforts to successfully innovate and integrate critical technologies necessary to meet the metrics of the NOW program. \nAttendance at this event is not a requirement for submission of a proposal or selection for\nfunding. Information relayed during the Proposers Day will be made available on the BTO\nsection of the DARPA Opportunities page. \nAttendance is open to individuals who are U.S. Citizens\, U.S. Permanent Residents\, and Foreign Nationals. Upon entry to the physical meeting\, all attendees will be required to present valid\, Government-issued photo identification. \nREGISTER HERE. Registration for physical participation will close on October 23\, 2019 at 12:00 PM ET (updated from original date of October 21\, 2019 at 12:00 PM ET) or when capacity is reached and webinar participation will close on October 25\, 2019 at 12:00 PM ET or when webinar capacity is reached\, whichever comes first.Registration is limited by the venue capacity\, and early registration is strongly recommended. There will be no on-site registration. \nGlobal Biodefense is a publisher providing visibility on this important development program. For all attendance or logistics information\, please contact the event sponsor.
URL:https://globalbiodefense.com/event/darpa-proposers-day-nucleic-acids-on-demand-worldwide-now/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20190914T001844Z
CREATED:20190722T154929Z
LAST-MODIFIED:20190914T001844Z
UID:29649-1571097600-1571270399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2019
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) annual Industry Day 2019 conference on U.S. government medical countermeasures is planned for 15-16 October 2019 in Washington\, D.C. \nA component of the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR)\, BARDA will brief on program priorities and network with public and private sector colleagues on developing medical countermeasure or platform technology to combat chemical\, biological\, radiological\, or nuclear (CBRN) threats\, pandemic influenza or other emerging infectious diseases. \nThe Industry Day event will be held at Grand Hyatt and Washington Marriott at Metro Center in Washington\, DC. \nBARDA Industry Day brings together over >1\,000 participants to exchange information about the government’s public health needs\, and industry’s technologies\, capabilities\, and products that can fill those requirements. \nLightning Talks to showcase innovative discoveries and promote networking growth at the conference will be featured on the morning of October 16th. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nLightning Talk applications must be received by 11:59 PM ET September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. Learn more here. \nPlease visit MedicalCountermeasures.gov or http://bit.ly/BARDA2019 for official updates in the BID 2019 event.
URL:https://globalbiodefense.com/event/barda-industry-day-2019/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/07/barda-industry-day-aspr-register.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190517
DTEND;VALUE=DATE:20190518
DTSTAMP:20190513T160228Z
CREATED:20190504T154020Z
LAST-MODIFIED:20190513T160228Z
UID:27240-1558051200-1558137599@globalbiodefense.com
SUMMARY:DARPA ReVector Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. \nThe goal of ReVector is to develop an easily delivered treatment — for example\, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes. \nThe Proposers Day will include overview presentations by DARPA personnel and potential government partners; an information session during which government personnel will respond to questions posed by participants; “lightning” talks (three minutes\, one slide) to allow potential proposers to highlight technical capabilities of interest and promote teaming; and short sidebars with DARPA personnel for discussion of any proprietary information that participants would not want to disclose in the other open sessions. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nDue to space limitations\, attendance is limited to no more than three attendees per division/department unless capacity is not reached. \nParticipants must register in advance through the registration website. You will be required to show government-issued\, picture identification that is compliant with the REAL ID Act of 2005. \nInformation about registration and various other meeting details can be found at the registration website. \nFurther administrative questions should be addressed to DARPA-SN-19-48@darpa.mil. Please refer to the ReVector Proposers Day (DARPA-SN-19-48) in all correspondence. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the ReVector Proposers Day is open only to registered potential applicants\, and not to the media or general public.
URL:https://globalbiodefense.com/event/darpa-revector-proposers-day/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/05/darpa-bto-revector-proposers-day.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181214
DTEND;VALUE=DATE:20181215
DTSTAMP:20181224T223152Z
CREATED:20181201T173734Z
LAST-MODIFIED:20181224T223152Z
UID:19521-1544745600-1544831999@globalbiodefense.com
SUMMARY:DARPA Panacea Program - Accessing the Dark Proteome
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. \nThe event will be held on December 14\, 2018 from 10:00 AM to 2:00 PM EST at the Executive Conference Center (ECC; 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA 22203). Advance registration is required. \nPanacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction\, synthesis\, and validation of pharmacological interventions. \nNew drug development for the Panacea program will be focused towards solving two critical problems facing DoD personnel: alleviating pain/inflammation without unwanted side effects and positively mitigating metabolic stress. \nDARPA seeks to bridge the gaps between the chemical space required to identify and produce novel pharmacological interventions and the complex biological space whose functions must be quantified in order to predict and validate the benefits of those interventions for these two desired indications. \nThe success of the Panacea program will represent a paradigm shift in the new drug discovery process and provide new technology that enables more rapid\, safe and effective therapeutic drug development for military and civilian health. \nSpecifically excluded from this effort is research that primarily results in evolutionary improvements to the existing state of practice\, that requires genetic manipulation of the intended recipient\, or that relies on discovering novel pharmacodynamic space for known therapeutics to identify additional indications. \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xP6hD. Please address administrative questions to DARPA-SN-19-12@darpa.mil\, and refer to the Panacea Proposers Day (DARPA-SN-19-12) in all correspondence.
URL:https://globalbiodefense.com/event/darpa-panacea-program-accessing-the-dark-proteome/
LOCATION:Strategic Analysis Executive Conference Center\, 4075 Wilson Blvd.\, Suite 300\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/darpa-panacea-baa.jpg
END:VEVENT
END:VCALENDAR